Patent 7442551 was granted and assigned to Novartis on October, 2008 by the United States Patent and Trademark Office.
The present invention provides novel lentiviral packaging constructs that are useful for the establishment of stable packaging cell lines and producer cell lines. In particular, the present invention provides novel packaging cell lines that are capable of constitutively expressing high levels of lentiviral proteins.